102 related articles for article (PubMed ID: 23094764)
1. [The rational preoperative diagnosis of ovarian tumors - imaging techniques and tumor biomarkers (review)].
Fischerová D; Zikán M; Pinkavová I; Sláma S; Frühauf F; Freitag P; Dundr P; Burgetová A; Cibula D
Ceska Gynekol; 2012 Aug; 77(4):272-87. PubMed ID: 23094764
[TBL] [Abstract][Full Text] [Related]
2. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.
Nam EJ; Yun MJ; Oh YT; Kim JW; Kim JH; Kim S; Jung YW; Kim SW; Kim YT
Gynecol Oncol; 2010 Mar; 116(3):389-94. PubMed ID: 19926121
[TBL] [Abstract][Full Text] [Related]
4. Imaging techniques for the evaluation of ovarian cancer.
Fischerova D; Burgetova A
Best Pract Res Clin Obstet Gynaecol; 2014 Jul; 28(5):697-720. PubMed ID: 24846098
[TBL] [Abstract][Full Text] [Related]
5. Value of ultrasound and magnetic resonance imaging in the preoperative evaluation of suspected ovarian masses.
Huber S; Medl M; Baumann L; Czembirek H
Anticancer Res; 2002; 22(4):2501-7. PubMed ID: 12174952
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model.
Ocak M; Gillman AG; Bresee J; Zhang L; Vlad AM; Müller C; Schibli R; Edwards WB; Anderson CJ; Gach HM
Mol Pharm; 2015 Feb; 12(2):542-53. PubMed ID: 25536192
[TBL] [Abstract][Full Text] [Related]
7. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET/CT as a molecular biomarker in ovarian cancer.
Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
[TBL] [Abstract][Full Text] [Related]
9. MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.
Iyer VR; Lee SI
AJR Am J Roentgenol; 2010 Feb; 194(2):311-21. PubMed ID: 20093590
[TBL] [Abstract][Full Text] [Related]
10. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
11. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT of a benign ovarian Brenner tumor.
Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
[TBL] [Abstract][Full Text] [Related]
14. Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.
Fularz M; Adamiak P; Czepczyński R; Jarząbek-Bielecka G; Rewers A; Kędzia W; Ruchała M
Nuklearmedizin; 2015; 54(4):158-62. PubMed ID: 26076719
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer. Radiologic staging.
Thoeni RF
Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
[TBL] [Abstract][Full Text] [Related]
16. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
[TBL] [Abstract][Full Text] [Related]
17. PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.
Dauwen H; Van Calster B; Deroose CM; Op de Beeck K; Amant F; Neven P; Berteloot P; Leunen K; Timmerman D; Vergote I
Gynecol Oncol; 2013 Dec; 131(3):694-700. PubMed ID: 23988417
[TBL] [Abstract][Full Text] [Related]
18. [Benign and borderline tumors of the ovary].
Schem Ch; Bauerschlag DO; Meinhold-Heerlein I; Fischer D; Friedrich M; Maass N
Ther Umsch; 2007 Jul; 64(7):369-74. PubMed ID: 17948753
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of benign ovarian lesions using imaging techniques].
Walczewska M; Mocarska A; Burdan F; Janczarek M; Żelazowska-Cieślińska I; Starosławska E
Pol Merkur Lekarski; 2015 Jan; 38(223):55-60. PubMed ID: 25763591
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]